The effect of 0.1% topical ciclosporin a for 12-weeks on the ocular surface innate and adaptive immune response in dry eye disease: protocol for a randomized controlled clinical trial.

Sadhu S, Jalbert I, Wu M, Karimi F, Alghamdi A, Downie LE, Stapleton F

Open source

DOI
10.1080/07853890.2026.2729947
Published
2026 Dec
Container
Annals of medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/07853890.2026.2729947,
  title = {The effect of 0.1\% topical ciclosporin a for 12-weeks on the ocular surface innate and adaptive immune response in dry eye disease: protocol for a randomized controlled clinical trial.},
  author = {Sadhu S and Jalbert I and Wu M and Karimi F and Alghamdi A and Downie LE and Stapleton F},
  year = {2026},
  journal = {Annals of medicine},
  doi = {10.1080/07853890.2026.2729947},
  url = {https://doi.org/10.1080/07853890.2026.2729947}
}

RIS

TY  - JOUR
TI  - The effect of 0.1% topical ciclosporin a for 12-weeks on the ocular surface innate and adaptive immune response in dry eye disease: protocol for a randomized controlled clinical trial.
AU  - Sadhu S
AU  - Jalbert I
AU  - Wu M
AU  - Karimi F
AU  - Alghamdi A
AU  - Downie LE
AU  - Stapleton F
PY  - 2026
JO  - Annals of medicine
DO  - 10.1080/07853890.2026.2729947
UR  - https://doi.org/10.1080/07853890.2026.2729947
ER  - 

APA

S, S., I, J., M, W., F, K., A, A., LE, D., & F, S. (2026). The effect of 0.1% topical ciclosporin a for 12-weeks on the ocular surface innate and adaptive immune response in dry eye disease: protocol for a randomized controlled clinical trial.. Annals of medicine. https://doi.org/10.1080/07853890.2026.2729947

Source records